Aummune Israeli Company

Aummune is a clinical stage company developing a first-of-its-kind approach for individualized treatment of solid tumors. Its proprietary platform utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional oligonucleotide drug that safely and synergistically induces cancer cell death and activates both innate and adaptive immune responses.